Literature DB >> 15928306

Cancer as a risk factor for long-term cognitive deficits and dementia.

Lara H Heflin1, Beth E Meyerowitz, Per Hall, Paul Lichtenstein, Boo Johansson, Nancy L Pedersen, Margaret Gatz.   

Abstract

Previous studies have shown that cancer survivors frequently experience short-term cognitive deficits, but it is unknown how long these deficits last or whether they worsen over time. Using a co-twin control design, the cognitive function of 702 cancer survivors aged 65 years and older was compared with that of their cancer-free twins. Dementia rates were also compared in 486 of the twin pairs discordant for cancer. Cancer survivors overall, as well as individuals who had survived cancer for 5 or more years before cognitive testing, were more likely than their co-twins to have cognitive dysfunction (odds ratio [OR] = 2.10, 95% confidence interval [CI] = 1.36 to 3.24; P<.001; and OR = 2.71, 95% CI = 1.47 to 5.01; P<.001, respectively). Cancer survivors were also twice as likely to be diagnosed with dementia as their co-twins, but this odds ratio did not reach statistical significance (OR = 2.0, 95% CI = 0.86 to 4.67; P = .10). These results suggest that cancer patients are at increased risk for long-term cognitive dysfunction compared with individuals who have never had cancer, even after controlling for the influence of genetic factors and rearing environment.

Entities:  

Mesh:

Year:  2005        PMID: 15928306     DOI: 10.1093/jnci/dji137

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  29 in total

1.  Improving quality of life among latino cancer survivors: Design of a randomized trial of patient navigation.

Authors:  Amelie G Ramirez; Kipling J Gallion; Arely Perez; Edgar Munoz; Dorothy Long Parma; Patricia I Moreno; Frank J Penedo
Journal:  Contemp Clin Trials       Date:  2018-11-03       Impact factor: 2.226

Review 2.  Candidate mechanisms for chemotherapy-induced cognitive changes.

Authors:  Tim A Ahles; Andrew J Saykin
Journal:  Nat Rev Cancer       Date:  2007-03       Impact factor: 60.716

3.  Pooled analysis of two case-control studies on use of cellular and cordless telephones and the risk for malignant brain tumours diagnosed in 1997-2003.

Authors:  Lennart Hardell; Michael Carlberg; Kjell Hansson Mild
Journal:  Int Arch Occup Environ Health       Date:  2006-03-16       Impact factor: 3.015

Review 4.  Memory and cancer: a review of the literature.

Authors:  Graham J McDougall; JoAnn S Oliver; Forrest Scogin
Journal:  Arch Psychiatr Nurs       Date:  2014-03-22       Impact factor: 2.218

Review 5.  Chemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapy.

Authors:  Xiao-Min Wang; Brian Walitt; Leorey Saligan; Agnes F Y Tiwari; Chi Wai Cheung; Zhang-Jin Zhang
Journal:  Cytokine       Date:  2015-01-05       Impact factor: 3.861

Review 6.  Clearing the air: a review of our current understanding of "chemo fog".

Authors:  Erin O'Farrell; Joyce MacKenzie; Barbara Collins
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

7.  Understanding the symptom experience of patients with gastrointestinal cancers in the first year following diagnosis: findings from a qualitative longitudinal study.

Authors:  J Ellis; S G Brearley; O Craven; A Molassiotis
Journal:  J Gastrointest Cancer       Date:  2013-03

Review 8.  Brain vulnerability to chemotherapy toxicities.

Authors:  Tim A Ahles
Journal:  Psychooncology       Date:  2012-10-01       Impact factor: 3.894

9.  Long-term cognitive impairment in older adult twins discordant for gynecologic cancer treatment.

Authors:  Keiko Kurita; Beth E Meyerowitz; Per Hall; Margaret Gatz
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-08-22       Impact factor: 6.053

10.  Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain.

Authors:  G Joshi; C D Aluise; M P Cole; R Sultana; W M Pierce; M Vore; D K St Clair; D A Butterfield
Journal:  Neuroscience       Date:  2010-01-20       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.